AI assistant
Sending…
Compass Therapeutics, Inc. — Director's Dealing 2018
Jul 30, 2018
32588_dirs_2018-07-30_e7008774-503b-496b-a99c-556d2d103b8f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Olivia Ventures, Inc. (NONE)
CIK: 0001738021
Period of Report: 2018-07-29
Reporting Person: Jacobs Ian Seth (Director, President, Sec, CEO, & CFO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.0001 | 250000 | Direct |
More from Compass Therapeutics, Inc.
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Jan 12
Regulatory Filings
2026
Jan 8
Regulatory Filings
2026
Jan 6
Director's Dealing
2026
Jan 5